期刊文献+

慢性阻塞性肺疾病中医药治疗方案的构建及其临床评价

Construction and Clinical Evaluation of TCM Treatment Plan for Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:研究慢性阻塞性肺疾病中医药治疗方案的构建和临床价值。方法:选取2019年2月至2020年2月在我院入院治疗的慢性阻塞性肺疾病患者64例纳入研究,按照随机数表将所有患者均分成2组,研究组(32例)和普通组(32例)。普通组实施传统诊治,研究组采取中医药诊治方案,观察两组患者临床疗效以及住院时间情况。结果:经治疗后,较于普通组,研究组的临床有效率更高,住院时间更短,组间数据对比具有明显的差异,具备统计学意义(P<0.05)。结论:因此可看出,对慢性阻塞性肺疾病患者运用中医药治疗方案,可有效缩短患者住院时间,控制住院费用费用,提升临床效果,可在临床实践应用推广。 Objective:To study the construction and clinical value of TCM treatment plan for COPD.Methods:64 patients with COPD admitted to our hospital from February 2019 to February 2020 were enrolled in the study.All patients were divided into two groups according to the random number table:the study group(32 cases)and the general group(32 cases).The traditional diagnosis and treatment was carried out in the common group,and the traditional Chinese medicine diagnosis and treatment program was adopted in the research group.Results:After treatment,compared with the common group,the clinical efficiency of the study group was higher,the length of stay was shorter,and there was significant difference between the two groups(P<0.05).Conclusion:It can be seen that the use of traditional Chinese medicine treatment program for patients with chronic obstructive pulmonary disease can effectively shorten the length of stay,control the cost of hospitalization,improve the clinical effect,and can be applied in clinical practice.
作者 梅文星 朱文平 韩旭东 MEI Wen-xing;ZHU Wen-ping;HAN Xu-dong(Pulmonary Disease Department,Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Traditional Chinese Medicine,Changzhou Jiangsu 213000,China)
出处 《医学食疗与健康》 2020年第12期13-14,共2页 Medical Diet and Health
关键词 慢性阻塞性肺疾病 中医药治疗方法 临床评价 Chronic Obstructive Pulmonary Disease Traditional Chinese Medicine Treatment Clinical Evaluation
  • 相关文献

参考文献4

二级参考文献48

  • 1何权瀛.切实搞好慢性阻塞性肺疾病的教育和管理[J].中华结核和呼吸杂志,2007,30(1):6-7. 被引量:31
  • 2李建生,李素云,王明航.慢性阻塞性肺疾病的功能状态和健康相关生存质量的变化[J].河南中医学院学报,2007,22(1):19-22. 被引量:10
  • 3李建生,王至婉,李素云,等.慢性阻塞性肺疾病中医证候诊断标准(讨论稿)[C].中华中医药学会内科分会.全国中医内科肺系病第十四次学术研讨会论文集,2010:428-431. 被引量:7
  • 4Jones PW,Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease[J]. Eur Respir J, 2006,27(4):822 - 832. 被引量:1
  • 5Franciosi LG, Page CP, Celli BR, et al. Markers of disease severity in chronic obstructive pulmomary disease [J]. Pulm Pharmacol Ther,2006,19(3) : 189 - 199. 被引量:1
  • 6Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers[J]. Eur Respir J,2008, 31(2): 416 - 469. 被引量:1
  • 7Lacoma A, Prat C, Andreo F, et al. Biomarkers in the management of COPD[J]. Eur Respir Rev, 2009, 18 (112) :96 - 104. 被引量:1
  • 8Jones PW, Harding G,Berry P,et al. Development and first validation of the COPD Assessment Test[J]. Eur Respir J, 2009,34(3) :648-654. 被引量:1
  • 9McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee[J]. Thorax, 2007,62(5):411 - 415. 被引量:1
  • 10Celli B, Decramer M, Kesten S, et al. Mortality in the 4-Year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med ,2009,180(10): 948 - 955. 被引量:1

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部